logo image
search icon
Global mRNA Treatment Market

Global mRNA Treatment Market Size, Share & Trends Analysis Report By Product Type (Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs), By Therapeutic Area, By Route of Administration, By Region, And Segment Forecasts, 2023-2031

Report ID : 1110 | Published : 2024-05-27 | Pages: 185 | Format: PDF/EXCEL

The Global mRNA Treatment Market Size is valued at 31815.0 Million in 2022 and is predicted to reach 37463.3 Million by the year 2031 at a 1.9% CAGR during the forecast period for 2023-2031.

Key Industry Insights & Findings from the Report:

  • The increasing existance of chronic diseases such as cancer, viral infections, and genetic disorders is driving the demand for mRNA treatments.
  • The development of advanced lipid nanoparticle formulations for in vivo systemic delivery of mRNA is fueling the mRNA treatment market.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • The key challenges for the mRNA treatment market are process of vaccine and drug development is time-consuming and requires extensive clinical trials to ensure safety and efficacy.

mRNA Treatment Market

The mRNA Treatment has various advantages, including vaccine preparation. mRNA is the biological preparation that induced active acquired immunity to a particular disease by stimulating the body’s immune system. Moreover, the advancement of lipid nanoparticle formulations for in vivo systemic delivery of mRNA fueling the development of in vivo transfection strategies.

The increasing prevalence of cancer, viral infections, and genetic disorders drive the mRNA treatment market. Additionally, raising awareness about vaccination fueling the global mRNA market. Furthermore, mRNA is being used to produce viral antigen proteins from within the cell are one of the promising therapies for viral disease. For instance, due to the outbreak of COVID-19 number of companies conducting clinical trials for vaccine development is projected to create lucrative opportunities in the near future. North America is dominating the market owing to the presence of key players in the region.

Competitive Landscape

Some Of The Key Players In The mRNA Treatment Market:

  • CureVac,
  • Moderna,
  • BioNTech (Pfizer),
  • Translate Bio,
  • Ethris (AstraZeneca),
  • Kernal Biologics,
  • Anima Biotech,
  • H3 Biomedicine Inc.,
  • Arcturus Therapeutics,
  • eFFECTOR Therapeutics, Inc.,
  • Ionis Pharmaceuticals, Inc.,
  • Stemirna Therapeutics Co., Ltd.,
  • Skyhawk Therapeutics, Inc.,
  • RNAimmune (Sirnaomics),
  • Ziphius Therapeutics NV,
  • miRagen Therapeutics, Inc.,
  • Silence Therapeutics,
  • eTheRNA,
  • Tiba Biotechnology,
  • In-Cell-Art,
  • Arcturus Therapeutics

Market Segmentation

The Global mRNA Treatment market is segmented on the basis of product type, Therapeutic Area, Route of Administration, and region. Based on the product type, the market is divided into Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs. On the basis of Therapeutic Area, the market is divided into Infectious Diseases, Oncological Disorders, Other Disorders. On the basis of Route of Administration, the market is divided into Intravenous, Intramuscular, Intranasal, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

Recent Developments:

  • In September 2023, Ethris and Heqet Therapeutics worked together to develop RNA-based cardiovascular therapeutics. Ethris granted the utilisation of its exclusive Stabilised NanoParticle (SNaP) lipid nanoparticle (LNP) platform in return for milestone and royalty payments as stipulated in this agreement. With an emphasis on remedies for heart failure and myocardial infarction, Heqet oversaw the drug development efforts.

 

mRNA Treatment Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 31815.0 Million

Revenue Forecast In 2031

USD 37463.3 Million

Growth Rate CAGR

CAGR of 1.9 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By Therapeutic Area, By Route of Administration

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Kernal Biologics, Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics, eFFECTOR Therapeutics, Inc., Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., Skyhawk Therapeutics, Inc., RNAimmune (Sirnaomics), Ziphius Therapeutics NV, miRagen Therapeutics, Inc., Silence Therapeutics, eTheRNA, Tiba Biotechnology, In-Cell-Art, Arcturus Therapeutics among others.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global mRNA Treatment Market Snapshot

Chapter 4. Global mRNA Treatment Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Clinical Trial/Pipeline Analysis

4.7. COVID 19 Impact Analysis on Healthcare Industry

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Product Type:

5.2.1. Prophylactic vaccines

5.2.2. Therapeutic vaccines

5.2.3. Therapeutic drugs

Chapter 6. Market Segmentation 2: Therapeutic Area Estimates & Trend Analysis

6.1. Therapeutic Area & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Therapeutic Area:

6.2.1. Infectious Diseases

6.2.2. Oncological Disorders

6.2.3. Other Disorders

Chapter 7. Market Segmentation 3: Route of Administration Estimates & Trend Analysis

7.1. Route of Administration & Market Share, 2019 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Route of Administration:

7.2.1. Intravenous

7.2.2. Intramuscular

7.2.3. Intranasal

7.2.4. Others

Chapter 8. mRNA Treatment Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Product Type, 2020-2030

8.1.2. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Therapeutic Area, 2020-2030

8.1.3. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Route of Administration, 2020-2030

8.1.4. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe mRNA Treatment Market revenue (US$ Million) by Product Type, 2020-2030

8.2.2. Europe mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.2.3. Europe mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.2.4. Europe mRNA Treatment Market revenue (US$ Million) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Product Type, 2020-2030

8.3.2. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.3.3. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.3.4. Asia Pacific mRNA Treatment Market revenue (US$ Million) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America mRNA Treatment Market revenue (US$ Million) by Product Type, (US$ Million)

8.4.2. Latin America mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.4.3. Latin America mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.4.4. Latin America mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Product Type, (US$ Million)

8.5.2. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, (US$ Million)

8.5.3. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Route of Administration (US$ Million)

8.5.4. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. CureVac

9.2.2. Moderna

9.2.3. BioNTech (Pfizer)

9.2.4. Translate Bio(Sanofi)

9.2.5. Ethris (AstraZeneca)

9.2.6. Kernal Biologics

9.2.7. Silence Therapeutics

9.2.8. eTheRNA (Etherna Immunotherapies)

9.2.9. Tiba Biotechnology

9.2.10. In-Cell-Art

9.2.11. Anima Biotech

9.2.12. H3 Biomedicine Inc.

9.2.13. Arcturus Therapeutics

9.2.14. eFFECTOR Therapeutics, Inc.

9.2.15. Ionis Pharmaceuticals, Inc.

9.2.16. Stemirna Therapeutics Co., Ltd.

9.2.17. Skyhawk Therapeutics, Inc.

9.2.18. RNAimmune (Sirnaomics)

9.2.19. Ziphius Therapeutics NV

9.2.20. miRagen Therapeutics, Inc.

9.2.21. GlaxoSmithKline plc

9.2.22. Other Prominent Players

Global mRNA Treatment Market Segmentation:

Global mRNA Treatment Market Revenue (US$ Mn) by Product Type

  • Prophylactic vaccines
  • Therapeutic vaccines
  • Therapeutic drugs

mRNA Treatment Market

Global mRNA Treatment Market Revenue (US$ Mn) Based on Therapeutic Area

  • Infectious Diseases
  • Oncological Disorders
  • Other Disorders

Global mRNA Treatment Market Revenue (US$ Mn) Based on Route of Administration

  • Intravenous
  • Intramuscular
  • Intranasal
  • Others

Global mRNA Treatment Market Revenue

Global mRNA Treatment Market Revenue (US$ Mn) Based on Region

Europe mRNA Treatment Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America mRNA Treatment Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific mRNA Treatment Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America mRNA Treatment Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa mRNA Treatment Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the mRNA Treatment Market Size?

The Global mRNA Treatment Market is expected to grow at a 1.9% CAGR during the forecast period for 2023-2031.

CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Kernal Biologics, Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3986
$5786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach